Wider effects In any event, the incident itself is often quite small (and completely avoidable if you follow sops and concentrate (your reported learning)

Slides:



Advertisements
Similar presentations
What Analgesics? Paracetamol – Aspirin Nefopam NSAIDS Opioids
Advertisements

Cindy Powers Magrini, PharmD, BCPS
Medicines Management Waste Campaign 2014 Jennifer Bartlett – Senior Medicines Management Adviser Nicola Swindell – Medicines Management Team Co-ordinator.
Powys-wide, Primary care audit Rhiannon Davies, Powys tHB Medicines Management Team Prescribing of Antipsychotic Medication in Patients with Dementia.
Protecting patients- now and in the future Linda Matthew Senior Pharmacist National Patient Safety Agency.
Opioid Use: What are the technological, clinical, ethical, and regulatory issues? Michael Von Korff Group Health Research Institute.
What are we doing in Southern Oregon? Concerns about opioid prescribing practices.
Repeat Dispensing Sue Carter Regional Tutor Hampshire and IOW 1.
Opiates in Chronic Pain Dr S Vas, Barnsley VTS October 2014.
Medications for Pain: What You Need to Know for Treatment in Workers’ Compensation Suzanne Novak, MD, PhD 5/17/07.
High Risk Medications Narcotics and Sedatives Alex Kardos R.Ph. Director of Pharmacy Services Robert Wood Johnson University Hospital Hamilton.
Using drug use evaluation (DUE) to optimise analgesic prescribing in emergency departments (EDs) Karen Kaye, Susie Welch. NSW Therapeutic Advisory Group*
Case study Which antidepressant Dr. Matthew Miller.
Audit of psychotropic medication prescribing in EMI nursing homes in Monmouthshire Dr Pauline Ruth Dr Rui Zheng Dr Arpita Chakraborty Dr Usman Mansoor.
Safe use of HYDROmorphone
Prepared by Dr. Ramin Safakish, MD, FRCPC – March 2016.
CDC Guideline for Prescribing Opioids for Chronic Pain- United States-2016 Gisele J. Girault, M.D. First Choice Healthcare Columbia, SC.
COMMUNITY PHARMACY WORKBOOK PUBLIC HEALTH DORSET
The recovery agenda – a pharmacy perspective
Easy wins in General Practice
APPG for prescribed drug dependence
USING MEDICINES SAFELY how carers can help
WITHDRAWING NIV AT THE END OF LIFE IN MOTOR NEURONE DISEASE
Bone Pain: A Practical Approach to Management
Audit Opioid use in palliative patients on general hospital wards
Jessica E. Bates, Pharm.D. PGY-1 Pharmacy Resident
Opioids for the management chronic non-cancer pain in Primary Care:
Opioid Medication Assisted Tx (1)
Opioids for chronic non-cancer pain? Which ones.....if any?
Cover slide.
Opioids Aware A resource for patients and healthcare professionals to support prescribing of opioid medicines for pain.
AN UPDATE FROM THE OFFICE OF THE MEDICAL DIRECTOR
Tapering Opioids (1) C.L.I.P.S.
Methotrexate in Psoriasis Shared Care Guidelines
Effectiveness of Care Measures
Opioids Aware A resource for patients and HCPs to support prescribing of opioid medicines for pain Sue Mulvenna CDAO NHSE S SW March 2016.
Opioids in chronic pain
Protocol References Section Title 6.2 Entry Visit 5.1
Batch Prescribing Repeat Dispensing
Medicines Management Tips & Preparing for your CQC Inspection with Gerry Devine Practice Management Advisor.
OPIOID SAFETY. Indiana Statistics In Summary… About 100 Hoosiers die from drug overdoses every month, many from opioids such as heroin and prescription.
Opioid Crisis A Call to ACTION
Risk evaluation and mitigation for use of opioids in chronic pain
Cancer Pain David Cameron
Opioid Prescribing & Monitoring
Medication Effects That May Impair Driving Ability
Scottish Patient Safety Programme
Oxycontin.
Barbara Allison-Bryan, MD
2017 Opioid Prescriber Survey Preliminary Results
Electronic Prescription Service
Class Medication Recommendatio n Starting dose Max dose Adequate Trial
Opioids in Butte County
Just In Case Scheme Update 2018.
MOCH (Medicines Optimisation in Care Homes) Pharmacists
2019 Medicare Part D Rule Opioid-related Provisions
Background Cancers are among the leading causes of morbidity and mortality worldwide, responsible for 18.1 million new cases and 9.6 million deaths in.
Dry Eyes – Lubricant Eye Drops
EPS “Developing the best way forward for practices and pharmacy to maximise EPS”
Essentials of Good Pain Care: A Team-Based Approach
Opioid prescribing workflow in the electronic medical record.
Annual health checks for people with learning disability
COMMUNITY PHARMACY WORKBOOK 2019 PUBLIC HEALTH DORSET
Persistent pain management An update
Considering Monitored Dosage Systems?
Recognition of Opioid Overdose
Flowchart for Falls Referral
Insulin safety – shared learning
If pregabalin is unsuitable for some - or many
Pregabalin An Overview
Presentation transcript:

Wider effects In any event, the incident itself is often quite small (and completely avoidable if you follow sops and concentrate (your reported learning) and while it is not often that the consequences are catastrophic, it is often just the start of a change in the patient’s care. Many incidents are like an unravelling ball of wall, or the hem of your trousers, I pick and pick at it gets messier and messier!

Side effects Constipation Nausea Dizziness Drowsiness Respiratory depression Dry mouth Itching Rash Hypogonadism and adrenal insufficiency Amenorrhoea Reduced libido Erectile dysfunction depression Hyperalgesia Side effects are very common (50 – 80% of patients) and up to a quarter of patients taking opioids long term have developed a dependence on them.   Of all deaths related to drug poisoning in 2015, 54% involved an opioid drug. (ONS, 2016).

Chronic pain >120mg OME Gabapentinoids Benzodiazepines Hypnotics TCA SSRI Antipsychotics Magic number! We now have guidance about the threshold for prescribing opioids where harm starts to out weigh benefit. 120mg. Australia are now suggesting 80-100mg top whack in primary care https://www.racgp.org.au/your-practice/guidelines/drugs-of-dependence-a/appendix-d-example-practice-policies/D9-Practice-policy-%E2%80%93-Opioid-dosing-thresholds/ But we’re also going back to basics to say if the starting dose isn’t working – don’t increase, stop. Because…….it’s not working. Analysis local coroners’ reports suggests links between premature death and combinations of different drug classes. (Opioids, gabapentinoids, benzodiazepines or hypnotics, tricyclics, SSRIs, some antipsychotics). http://www.fpm.ac.uk/faculty-of-pain-medicine/opioids-aware

NHS England / PrescQIPP Audit https://www.prescqipp.info/resources/category/428-community- pharmacy-opiate-searches NHS England developed a multidisciplinary audit. General practice have been provided with some searches – but inevitably these won’t capture everyone we need to be concerned about – because e.g. more than one drug. So the CDAO team would also like community pharmacy to highlight potentially inappropriate prescriptions to the GP and engage patients – e.g. MUR To reiterate, we are looking at chronic pain (or acute pain that is becoming chronic) rather than acute pain or palliative care (although keeping checking suitability of CSCI scripts – NPSA, dose increases & conversions etc) Third document is a letter to GP requesting action “How to clinical audit” is instructions for using the data collection form 4th document is details and dose equivalence

Audit Criteria 1. Pharmacy to contact their GP in all instances where: a) Patient is taking >120mg oral morphine equivalent as a result multiple opioids b) Patient is regularly ordering/collecting prescriptions early that suggests they are taking more than the prescribed dose of opioids or pregabalin c) Patient is prescribed more than one immediate release ‘top up’ opioid

2. Is there a record on the PMR made in the last 15 months that at the point of supply: a) Patient is advised about safe storage of controlled drugs in their home with respect to risk of accidental overdose of family members. Is there a record on PMR of this being done in the last 15 months? b) Patient is advised about impaired driving ability

Don’t forget Benzodiazepines Hypnotics With all the attention opioids are getting, we mustn’t forget the over prescribing of benzos and z-hypnotics